Abstract:Podophyllotoxin, as a natural lignan isolated from the dried rhizomes and roots of several plant species of Podophyllum family, exhibits potent activity of interfering polymerization of tubulin and causes cancer cell apoptosis. Structure-activity relationship research revealed that modification at 4-position was tolerable for its potency. In the present study, podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties at 4-position were designed and synthesized. Their structures were confirmed by 1H NMR, 13C NMR, and mass spectral data. ADMET analysis proposed that these compounds had a good distribution and high clearance profile with little toxicity. The cytotoxicity of these derivatives was evaluated against four human cancer cell lines (MCF-7, A549, HeLa and PC-3) by MTT assay. Among all the compounds, compound 6e exhibited the best anti-proliferative properties with an IC50 = 0.08 ± 0.01 μM against MCF-7 cancer cell line. Further cellular mechanism studies by cell colony formation, mitochondrial membrane potential assay, nuclear morphology analysis and western blot confirmed that compound 6e could inhibit cancer cell proliferation and induce mitochondria-associated apoptosis in MCF-7 cells. Meanwhile, immunofluorescence assay revealed that compound 6e could apparently disrupt tubulin network in MCF-7 cells, and molecular docking further supported that compound 6e was able to bind into the colchicine site of tubulin. The above results might lay a foundation for further investigation for drug discovery based on podophyllotoxin.

A Review On Hemisynthesis, Biosynthesis, Biological Activities, Mode Of Action, And Structure-Activity Relationship Of Podophyllotoxins: 2003-2007

Review on Biosynthesis of Podophyllotoxin

Synthesis of New Spin Labeled Derivatives of Podophyllotoxin As Potential Anticancer Agents

Podophyllotoxin Derivatives: Current Synthetic Approaches for New Anticancer Agents

Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020)

Podophyllotoxin, a medicinal agent of plant origin: past, present and future

Podophyllotoxin: Recent Advances in the Development of Hybridization Strategies to Enhance Its Antitumoral Profile

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Insight Into the Molecular Mechanism of Podophyllotoxin Derivatives as Anticancer Drugs

Advances of podophyllotoxin and its derivatives: Patterns and mechanisms

Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives

Syntheses and structure-activity relationship of podophyllotoxin derivatives as potential anticancer drugs

Production of podophyllotoxin from Podophyllum hexandrum: a potential natural product for clinically useful anticancer drugs

Synthesis and biological evaluation of cytotoxic activity of novel podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties

Biotechnological interventions for harnessing podophyllotoxin from plant and fungal species: current status, challenges, and opportunities for its commercialization

Synthesis and antitumor activity of new derivatives of podophyllotoxin

Podophyllotoxin: Current approaches to its biotechnological production and future challenges

Synthesis and Biological Evaluation of New 4Β-Anilino-4′-o-demethyl-4-desoxypodophyllotoxin Derivatives As Potential Antitumor Agents

C-4 analogues of podophyllotoxin as tubulin inhibitors: synthesis, biological evaluation, and structure-activity relationship